International Biomedical Ltd. Company Profile

Background

Overview

International Biomedical Ltd. is a privately held company based in Austin, Texas, specializing in the design, manufacture, and distribution of neonatal and perinatal medical devices. Established in 1976, the company has dedicated over four decades to providing innovative solutions aimed at improving outcomes for newborns and critically ill infants.

Mission and Vision

The company's mission is to deliver the best possible outcomes for newborn infants, the critically ill, and their families. This commitment is reflected in their focus on developing products that support neonatal transport, labor and delivery, NICU and nursery care, neuro NICU, and developmental care.

Industry Significance

Operating within the medical device industry, International Biomedical Ltd. holds a significant position in the neonatal and perinatal care sector. Their products are integral to neonatal intensive care units (NICUs), labor and delivery rooms, and during the transport of vulnerable infants, underscoring their impact on critical healthcare services.

Key Strategic Focus

Core Objectives

International Biomedical Ltd. aims to provide comprehensive neonatal and pediatric transport systems, ensuring the safety and well-being of infants during critical care and transport. Their product offerings are designed to meet the evolving needs of caregivers and their patients.

Areas of Specialization

The company specializes in several key areas:

• Neonatal Transport: Providing specialized equipment for the safe transport of premature and sick newborns.

• Labor & Delivery: Offering solutions that support the transition of infants from birth to neonatal care.

• NICU & Nursery: Supplying equipment tailored for neonatal intensive care units and nurseries.

• Neuro NICU: Developing products focused on the care of infants with neurological conditions.

• Developmental Care: Creating solutions that support the developmental needs of infants in critical care settings.

Key Technologies Utilized

International Biomedical Ltd. employs advanced technologies in their products, including:

• Transport Incubators: Customized for air and ground transport, ensuring optimal conditions for neonatal patients.

• Blood Gas and Chemistry Monitors: Enabling precise monitoring of neonatal health parameters.

• Radiation Attenuating Surgical Gloves: Designed to protect healthcare providers during procedures requiring fluoroscopy.

Primary Markets Targeted

The company's primary markets include hospitals, neonatal intensive care units, labor and delivery rooms, and neonatal transport services worldwide. Their products are utilized in various healthcare settings to support the care of newborns and critically ill infants.

Financials and Funding

Funding History

International Biomedical Ltd. has raised a total of $966,000 in funding, with the most recent round occurring on January 25, 2021. The funding was secured through a debt round, with the Paycheck Protection Program (PPP) being a notable investor.

Intended Utilization of Capital

While specific details on the utilization of the capital are not publicly disclosed, it is reasonable to infer that the funds have been allocated towards research and development, manufacturing enhancements, and expanding the company's product offerings to meet the needs of neonatal and perinatal care.

Pipeline Development

Specific details regarding the company's pipeline candidates, stages of clinical trials, target conditions, and relevant timelines for anticipated milestones are not publicly available. However, International Biomedical Ltd. continues to innovate and expand its product line to support neonatal and perinatal care.

Technological Platform and Innovation

Proprietary Technologies

International Biomedical Ltd. has developed several proprietary technologies, including:

• AirBorne Transport Incubators: Customized incubators designed for neonatal transport, ensuring optimal conditions during air and ground transport.

• BiliCocoon Fiber Optic Phototherapy System: A soft and flexible phototherapy treatment option compatible with warmers, incubators, and kangaroo care.

Significant Scientific Methods

The company employs advanced scientific methods in their product development, such as:

• High-Frequency Ventilation Integration: Incorporating high-frequency ventilation into transport incubators to support neonatal respiratory needs.

• Noninvasive Bilirubin Assessment Tool: A tool designed to assess bilirubin levels without the need for invasive procedures.

AI-Driven Capabilities

While specific AI-driven capabilities are not detailed, the company's commitment to innovation suggests ongoing efforts to integrate advanced technologies into their product offerings.

Leadership Team

Key Executives

• John Segars: Owner and CEO, leading the company's strategic direction and operations.

• Julie Esquell, CPA: Controller & HR Manager, overseeing financial management and human resources.

• Amy Pieper: Director of Regulatory Affairs, managing regulatory compliance and product approvals.

• Thomas McRoberts: Director of Engineering, leading product development and engineering initiatives.

• Alan Segars: Facility Manager, responsible for overseeing manufacturing facilities and operations.

• Joe Segars: Plant Manager, managing day-to-day manufacturing processes.

• Chris Martinez: Product Manager, overseeing product development and lifecycle management.

• Marijose Hurtado: Quality Engineer, ensuring product quality and compliance with industry standards.

• Caroline Strand: Marketing Communications Specialist, handling marketing and communications strategies.